What is the current and next Honkai Star Rail banner? If you want to pick up the best five-star characters for your team, then wishing on banners is your best bet. HSR banners rotate regularly ...

In this article, we are going to take a look at where AstraZeneca PLC (NASDAQ:AZN) stands against other best UK stocks to invest in. Like most of the world, the United Kingdom is also facing ...

AstraZeneca, one of the largest companies in Britain, was the biggest loser in the FTSE 100 yesterday, slumping 6.8pc, or 707p, to 9667p. It was followed by rival GSK, which tumbled 5.7 per cent ...

President Trump announced he would impose a 125% tariff on China for retaliating against the U.S., while also announcing a 90-day pause on some tariffs. Photo: Saul Loeb/AFP/Getty Images Just ...

UK retail investors upped their purchases of stocks substantially as Trump’s trade war crashed markets. The global trade war has kicked into a new gear and it’s bad news for some of the FTSE ...

AstraZeneca has been busy in recent years pumping up its oncology pipeline via a shopping list of assets and companies. Now, the U.K.-based pharma is overseeing a range of clinical trials to ...

Today's announcement could potentially add to a string of bad tariff news that has cost Roche 10.9%, Lilly 14%, and AstraZeneca stock 14.4% over the past week. Still, it remains to be seen ...

(Alliance News) - Daiichi Sankyo Co Ltd and AstraZeneca PLC on Tuesday said Datroway has secured EU approval to treat breast cancer patients. Daiichi Sankyo, a Tokyo-based pharmaceutical company ...

AstraZeneca is a top healthcare company with a robust pipeline of drugs in development. Uber Technologies has been a growth beast in recent years, and robotaxis could open up a huge opportunity ...

GSK and AstraZeneca fell by as much as 7% today as fears of new tariffs targeting the pharmaceuticals industry heaped more pain on the FTSE 100 index. London’s top flight gave up gains from ...

On March 28, 2025, Michael Tappin KC, sitting as a deputy judge of the High Court, refused to grant AstraZeneca (“AZ”) an interim injunction to restrain Glenmark from launching in the U.K. a ...

Results of the phase 2b PURSUIT study, which evaluated AZD0780 (AstraZeneca), an oral small molecule PCSK9 inhibitor, were presented at the American College of Cardiology Scientific Session.